Kliniske studier for Astma i South Carolina
9 studier for Astma søker deltakere på steder i South Carolina.
Offisiell studietekst (engelsk)
A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1,1-difluoroethane (HFA-152a) and HFA-1,1,1,2-tetrafluoroethane (134a)
- GSK Investigational Site, Spartanburg
- GSK Investigational Site, Spartanburg
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07645248A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
- GSK Investigational Site, Charleston
RekruttererFase 3
Alder 12 til 17 · Alle kjønn · Oppdatert 30. sep. 2026 · NCT05757102Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
- Research Site, Rock Hill
RekruttererFase 2
Alder 18 til 75 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06932263ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
- Enveda Investigative Site, North Charleston
RekruttererFase 2
Alder 18 til 75 · Alle kjønn · Oppdatert 24. sep. 2026 · NCT07301255A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)
- Research Site 16, Rock Hill
RekruttererFase 3
Alder 12 til 80 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07359846A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
- Clinical Research of Rock Hill, Rock Hill
RekruttererFase 2
Alder 18 til 70 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT06977581A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
- Teva Investigational Site 12107, Rock Hill
RekruttererFase 3
Alder 12 og eldre · Alle kjønn · Oppdatert 31. aug. 2026 · NCT06664619Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
- Research Site, Charleston
RekruttererFase 3
Alder 12 til 17 · Alle kjønn · Oppdatert 13. aug. 2026 · NCT06307665A Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients With Severe Asthma
- Research site, Rock Hill
RekruttererFase 2
Alder 18 til 75 · Alle kjønn · Oppdatert 28. jul. 2026 · NCT07532265Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.